← 產業報告目錄
Next-Generation Biomanufacturing Market Size, Share & Trends Analysis Report By Medical Applications (Monoclonal Antibodies, Hormones, Vaccines, Recombinant Proteins, Other Applications), By Products, By Workflow, By End-User, By Region, And By Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-21頁數 180報告編號 INSIGHTACE-0f1b88b96d
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The global Next-Generation Biomanufacturing Market is forecasted to increase at a compound annual growth rate of 12.6% throughout the 2025–2034 forecast period.
Next-Generation Biomanufacturing encompasses key industry insights & findings from the report:
Supportive regulatory frameworks and guidelines from agencies like the fda and ema encourage the adoption of next-generation biomanufacturing technol. The sector has gained traction as organizations seek innovative approaches to address evolving healthcare challenges.
Growth is bolstered by a convergence of factors: rising awareness among end users, continuous product innovation, and the mounting emphasis on efficiency and sustainability within the healthcare sector.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region forecasted to deliver the strongest growth trajectory through the forecast period, bolstered by demographic shifts and policy support.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Next-Generation Biomanufacturing Market Snapshot
Chapter 4. Global Next-Generation Biomanufacturing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Medical Applications, Estimates & Trend Analysis
5.1. By Medical Applications, & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Medical Applications:
5.2.1. Monoclonal Antibodies
5.2.2. Hormones
5.2.3. Vaccines
5.2.4. Recombinant Proteins
5.2.5. Other Applications
Chapter 6. Market Segmentation 2: By Products Estimates & Trend Analysis
6.1. By Products & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Products:
6.2.1. Continuous Upstream Biomanufacturing Products
6.2.2. Single-Use Upstream Biomanufacturing Products
6.2.3. Downstream Biomanufacturing Products
Chapter 7. Market Segmentation 3: By Workflow Estimates & Trend Analysis
7.1. By Workflow & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Workflow:
7.2.1. Upstream Biomanufacturing
7.2.2. Downstream Biomanufacturing
Chapter 8. Market Segmentation 4: By End-Users Estimates & Trend Analysis
8.1. By End-Users & Market Share, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End-Users
8.2.1. Biopharmaceutical Companies
8.2.2. CMOs/CDMOs
8.2.3. Research Institutions
Chapter 9. Next-Generation Biomanufacturing Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Next-Generation Biomanufacturing Market revenue (US$ Million) estimates and forecasts By Medical Applications, 2021-2034
9.1.2. North America Next-Generation Biomanufacturing Market revenue (US$ Million) estimates and forecasts By Products, 2021-2034
9.1.3. North America Next-Generation Biomanufacturing Market revenue (US$ Million) estimates and forecasts By Workflow, 2021-2034
9.1.4. North America Next-Generation Biomanufacturing Market revenue (US$ Million) estimates and forecasts by End-Users, 2021-2034
9.1.5. North America Next-Generation Biomanufacturing Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
9.2. Europe
9.2.1. Europe Next-Generation Biomanufacturing Market revenue (US$ Million) By Medical Applications, 2021-2034
9.2.2. Europe Next-Generation Biomanufacturing Market revenue (US$ Million) By Products, 2021-2034
9.2.3. Europe Next-Generation Biomanufacturing Market revenue (US$ Million) By Workflow, 2021-2034
9.2.4. Europe Next-Generation Biomanufacturing Market revenue (US$ Million) estimates and forecasts by End-Users, 2021-2034
9.2.5. Europe Next-Generation Biomanufacturing Market revenue (US$ Million) by country, 2021-2034
9.3. Asia Pacific
9.3.1. Asia Pacific Next-Generation Biomanufacturing Market revenue (US$ Million) By Medical Applications, 2021-2034
9.3.2. Asia Pacific Next-Generation Biomanufacturing Market revenue (US$ Million) By Products, 2021-2034
9.3.3. Asia Pacific Next-Generation Biomanufacturing Market revenue (US$ Million) By Workflow, 2021-2034
9.3.4. Asia Pacific Next-Generation Biomanufacturing Market revenue (US$ Million) estimates and forecasts by End-Users, 2021-2034
9.3.5. Asia Pacific Next-Generation Biomanufacturing Market revenue (US$ Million) by country, 2021-2034
9.4. Latin America
9.4.1. Latin America Next-Generation Biomanufacturing Market revenue (US$ Million) By Medical Applications, (US$ Million) 2021-2034
9.4.2. Latin America Next-Generation Biomanufacturing Market revenue (US$ Million) By Products, (US$ Million) 2021-2034
9.4.3. Latin America Next-Generation Biomanufacturing Market revenue (US$ Million) By Workflow, (US$ Million) 2021-2034
9.4.4. Latin America Next-Generation Biomanufacturing Market revenue (US$ Million) estimates and forecasts by End-Users, 2021-2034
9.4.5. Latin America Next-Generation Biomanufacturing Market revenue (US$ Million) by country, 2021-2034
9.5. Middle East & Africa
9.5.1. Middle East & Africa Next-Generation Biomanufacturing Market revenue (US$ Million) By Medical Applications, (US$ Million) 2021-2034
9.5.2. Middle East & Africa Next-Generation Biomanufacturing Market revenue (US$ Million) By Products, (US$ Million) 2021-2034
9.5.3. Middle East & Africa Next-Generation Biomanufacturing Market revenue (US$ Million) By Workflow, (US$ Million) 2021-2034
9.5.4. Middle East & Africa Next-Generation Biomanufacturing Market revenue (US$ Million) estimates and forecasts by End-Users, 2021-2034
9.5.5. Middle East & Africa Next-Generation Biomanufacturing Market revenue (US$ Million) by country, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Applikon Biotechnology BV
10.2.2. bbi-biotech GmbH
10.2.3. Danaher Corporation
10.2.4. Eppendorf AG
10.2.5. Esco Group of Companies
10.2.6. GEA Group Aktiengesellschaft
10.2.7. Meissner Filtration Products, Inc.
10.2.8. Merck KGaA
10.2.9. PBS Biotech, Inc.
10.2.10. Pierre Guérin
10.2.11. Sartorius AG
10.2.12. Shanghai Bailun Biotechnology Co. Ltd.
10.2.13. Solaris Biotechnology Srl.
10.2.14. Thermo Fisher Scientific Inc.
10.2.15. ZETA GmbH
10.2.16. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們